2022

Peer-reviewed Publications

  1. Hibino M, Verma S, Pandey A, Bisleri G, Yanagawa B, Verma R, Puar P, Quan A, Teoh H, Yau TM, Verma A, Ha ACT, Mazer CD, SEARCH-AF trial investigators. The impact of statins on post-discharge atrial fibrillation after cardiac surgery: Secondary analysis from a randomized trial. CJC Open. 2022 Dec 29;5(4):285-291
  2. Peterson MD, Garg V, Mazer CD, Chu MWA, Bozinovski J, Dagenais F, MacArthur RGG, Ouzounian M, Quan A, Jüni P, Bhatt DL, Marotta TR, Dickson J, Teoh H, Zuo F, Smith EE, Verma S; ACE CardioLink-3 Trial Working Group. A randomized trial comparing axillary versus innominate artery cannulation for aortic arch surgery. J Thorac Cardiovasc Surg. 2022 Nov;164(5):1426-1438.
  3. Moses S, Verma S, Mazer CD, Teoh H, Quan A, Jimenez-Juan L, Deva DP, Yan AT, Connelly KA. Impact of Empagliflozin on Left Ventricular Strain: Insights from the EMPA-HEART CardioLink-6 Randomized Clinical Trial. JACC Cardiovasc Imaging. 2022 Oct;15(10):1832-1834.
  4. Hibino M, Dhingra NK, Chan V, Mazer CD, Teoh H, Quan A, Verma R, Leong-Poi H, Bisleri G, Connelly KA, Verma S. Stage-Based Approach to Predict Left Ventricular Reverse Remodeling After Mitral Repair. Clin Cardiol. 2022 Sep;45(9):921-927.
  5. Hibino M, Pandey A, Chan V, Mazer CD, Dhingra NK, Bonneau C, Verma R, Quan A, Teoh H, Cheema A, Yanagawa B, Leong-Poi H, Connelly KA, Bisleri G, Verma S. Leaflet Resection vs Preservation for Degenerative Mitral Regurgitation: Functional Outcomes and Mitral Stenosis at 12 months in a Randomized Trial. Can J Cardiol. 2022 Jun;38(6):808-814.
  6. Rai A Connelly KA, Verma S, Mazer CD, Teoh H, Ng M-Y, Roifman I, Quan A, Pourafkari M, Jimenez-Juan L, Ramanan V, Ge Y, Deva DP, Yan AT. Empagliflozin Does Not Affect Left Ventricular Diastolic Function in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease: Insight from the EMPA-HEART CardioLink-6 Randomized Clinical Trial. Acta Diabetol. 2022 Apr;59(4):575-578.

Conference Abstracts

  1. Verma S, Mazer CD, Puar P, Mason T, Wang C-H, Akhavein F, Chang C-W, Liu M-H, Yang N-I, Chen W-S, Juan Y-H, Opingari E, Salyani Y, Barbour W, Pasricha A, Ahmed S, Kosmopoulos A, Kirubaharan A, Verma R, Moroney M, Bakbak E, Bhatt DL, Butler J, Kosiborod MN, Lam CSP, Hess DA, Coelho-Filho OR, Lafreniere-Roula M, Teoh H, Quan A, Leiter LA, Yan AT, Connelly KA. Empagliflozin and cardiac remodeling in people without diabetes: primary results of EMPA-HEART 2 CardioLink-7 randomized placebo-controlled trial.
    American Heart Association Scientific Sessions, Chicago, Illinois, USA, November 5-7, 2022.
    Circulation. 2022; 146 (25):e585-A19558.
  2. Chen C-H, Peterson MD, Hibino M, Mazer D, Chu MW, Dagenais F, Teoh H, Quan A, Dickson J, Verma S, Smith EE Acute Infarcts on Brain MRI Following Aortic Arch Repair With Circulatory Arrest: Insights From the ACE Cardiolink-3 Randomized Trial.
    American Heart Association Scientific Sessions, Chicago, Illinois, USA, November 5-7, 2022.
    Circulation. 2022; 146 (Suppl): A9865.
  3. Puar P, Hibino M, Teoh H, Quan A, Verma R, Mazer CD, Yan AT, Connelly KA, Verma S. Left ventricular mass predicts cardiac reverse remodeling in patients with type 2 diabetes and coronary artery disease who are treated with empagliflozin.
    American Heart Association Scientific Sessions, Chicago, Illinois, USA, November 5-7, 2022.
    Circulation. 2022; 146 (Suppl): A12880.
  4. Pandey A, Hibino M, Ha A, Quan A, Puar P, Pandey A, Verma R, Bisleri G, Verma A, Mazer C, Verma S on behalf of the SEARCH-AF trial investigators. Impact of diabetes and glucose-lowering therapy on post-operative atrial fibrillation after cardiac surgery: Secondary analysis of the SEARCH-AF CardioLink-1 randomized clinical trial.
    Annual Meeting of the Canadian Cardiovascular Society, Ottawa, Ontario, Canada, October 27-30, 2022.
    Can J Cardiol. 2022; 38 (10 Suppl 2): S192:P164.
  5. Rumman RK, Verma S, Chan V, Mazer CD, Quan A, Hibino M, de Varennes BE, Chu MWA, Latter DA, Teoh H, Yanagawa B, Leong-Poi H, Connelly KA. Predictors of mitral valve hemodynamics after mitral valve repair for degenerative mitral regurgitation: A sub-analysis of the CAMRA CardioLink-2 randomized trial.
    Annual Meeting of the Canadian Cardiovascular Society, Ottawa, Ontario, Canada, October 27-30, 2022.
    Can J Cardiol. 2022; 38 (10 Suppl 2): S212:P196.
  6. Puar P, Hibino M, Teoh H, Quan A, Verma R, Mazer CD, Yan AT, Connelly KA, Verma S. Left ventricular mass predicts cardiac reverse remodeling in patients treated with empagliflozin: An exploratory sub-analysis of the EMPA-HEART CardioLink-6 randomized controlled trial.
    Annual Meeting of the Canadian Cardiovascular Society, Ottawa, Ontario, Canada, October 27-30, 2022.
    Can J Cardiol. 2022; 38 (10 Suppl 2): S122:P038.
  7. Hibino M, Verma S, Quan A, Puar P, Verma R, Pandey A, Bisleri G, Verma A, Ha A, Mazer C. Predictors of mitral valve hemodynamics after mitral valve repair for degenerative mitral regurgitation: A sub-analysis of the CAMRA CardioLink-2 randomized trial.
    Annual Meeting of the Canadian Cardiovascular Society, October 27-30, Ottawa, Ontario, Canada
    Can J Cardiol. 2022; 38 (10 Suppl 2): S124:P041.
  8. Hibino M, Verma S, Pandey A, Quan A, Puar P, Verma R, Pandey A, Bisleri G, Verma A, Mazer CD, Ha A. Valvular surgery is associated with an increased risk of post-operative atrial fibrillation: Secondary analysis of the SEARCH-AF CardioLink-1 randomized trial.
    Annual Meeting of the Canadian Cardiovascular Society, Ottawa, Ontario, Canada, October 27-30, 2022
    Can J Cardiol. 2022; 38 (10 Suppl 2): S200:P216.
  9. Puar P, Mistry N, Connelly KA, Yan AT, Quan A, Teoh H, Pan Y, Verma R, Hess DA, Verma S, Mazer CD. Insulin-like growth factor binding protein-7 as a marker of cardiac reverse remodeling with empagliflozin: A secondary analysis of the EMPA-HEART CardioLink-6 randomized controlled trial.
    Annual Meeting of the Canadian Cardiovascular Society, Ottawa, Ontario, Canada, October 27-30, 2022.
    Can J Cardiol. 2022; 38 (10 Suppl 2): S122:P037.
  10. Rumman RK, Verma S, Chan V, Mazer CD, Quan A, de Varennes BE, Chu MWA, Latter DA, Teoh H, Yanagawa B, Leong-Poi H, Connelly KA. Predictors of mitral valve hemodynamics after mitral valve repair for degenerative mitral regurgitation: A subanalysis of the CAMRA randomized trial.
    43rd European Society of Cardiology Congress 2022, Barcelona, Spain, August 26-29, 2022.
    Eur Heart J. 2022; 43 (Suppl 2):2115.
  11. Hibino M, Verma S, Pandey A, Quan A, Verma A, Bisleri G, Mazer CD, Ha A on behalf of the SEARCH-AF trial investigators. Valvular surgery is associated with an increased risk of post-operative atrial fibrillation: Secondary analysis of the SEARCH-AF CardioLink-1 randomized trial.
    43rd European Society of Cardiology Congress 2022, Barcelona, Spain, August 26-29, 2022.
    Eur Heart J. 2022; 43 (Suppl 2):2163.
  12. Pandey A, Hibino M, Ha A, Quan A, Verma A, Bisleri G, Mazer CD, Verma S on behalf of the SEARCH-AF trial investigators. Impact of diabetes and glucose-lowering therapy on post-operative atrial fibrillation after cardiac surgery: Secondary analysis of the SEARCH-AF CardioLink-1 randomized clinical trial.
    43rd European Society of Cardiology Congress 2022, Barcelona, Spain, August 26-29, 2022.
    Eur Heart J. 2022; 43 (Suppl 2):508.
  13. Hibino M, Verma S, Pandey A, Quan A, Verma A, Bisleri G, Ha A, Mazer CD on behalf of the SEARCH-AF trial investigators. The impact of statin on post-operative atrial fibrillation after discharge from cardiac surgery: Secondary analysis of the SEARCH-AF CardioLink-1 randomized trial.
    43rd European Society of Cardiology Congress 2022, Barcelona, Spain, August 26-29, 2022.
    Eur Heart J. 2022; 43 (Suppl 2):2342.
  14. Puar P, Mistry N, Connelly KA, Yan AT, Quan A, Teoh H, Pan Y, Verma R, Hess DA, Verma S, Mazer CD. Insulin-like growth factor binding protein-7 as a predictor marker of cardiac remodelling and SGLT2-inhibitor meditated cardiac reverse remodelling in patients with type 2 diabetes and coronary artery disease.
    XXIV World Congress International Society for Heart Research, Berlin, Germany, June 12–15, 2022.
  15. Hibino M, Dhingra N, Chan V, Mazer CD, Teoh H, Quan A, Leong-Poi H, Connelly K, Verma S. Risk factors and functional outcomes of elevated mitral gradient after mitral repair for degenerative regurgitation, randomized controlled trial.
    102nd Annual Meeting of the American Association of Thoracic Society Boston, MA, USA. May 14 – 17, 2022.
  16. Hibino M, Pandey AK, Dhingra N, Chan V, Mazer CD, Teoh H, Quan A, Leong-Poi H, Connelly KA, Verma S. Resection mitral valve repair with small annuloplasty is at higher risk of functional mitral stenosis. American College of Cardiology ACC.2022 Scientific Sessions. Washington, DC, USA. April 2-4, 2022.
    J Am Coll Cardiol. 2022 Mar, 79 (Supplement) 1710.
  17. Hibino M, Dhingra N, Chan V, Mazer CD, Teoh H, Quan A, Leong-Poi H, Verma S, Connelly KA. Stage-based approach to predict left ventricular reverse remodelling after mitral repair.
    58th Annual Meeting of the Society of Thoracic Surgeons (STS 2022). Miami Beach, FL, USA. January 29-30, 2022.
© 2024 CardioLink Canada. All rights reserved